Our scalable approach


Support all the stages of the drug development, from early preclinical stage to clinical assay development.

All therapeutic areas
All therapeutic areas

Agile enough to analyze tissue samples across any therapeutic area, and from any organ class.


Supports TMA, whole slide, H&E, IHC, multiplex, fluorescent, bright-field, 2D, 3D, more.

Find out what we can do for you

Increase productivity
Get access to full digital assays to process your studies and save time
Find Out More
Create AI digital assays
Choose the AI development solution that fits the level of autonomy you need
Find Out More
Get accurate results
Receive accurate, unbiased and standardized results
Find Out More
Predict patient outcomes
Identify unique AI tissue insights in your samples that correlate with patient outcomes
Find Out More
Integrate AI into your regulatory environment
Use AI to your advantage in your CDx and IVD product development, or your GxP sample analysis
Find Out More
Contact Us
How can we help you?
Let’s Talk About It

Don’t take our word for it; here’s what our partners have to say:

Pharmaceutical Laboratory

Aurélie Auguste

Senior Biomarker ‘Molecular Histopathology’ Lab Head
As well as being able to deliver accurate and fully quantitative results during clinical trials, Keen Eye is, above all, a great partner capable of complying with our standard operating procedures and high expectations on quality.

Dr. Karine Mignon Godefroy

VP Head of R&D
Keen Eye offers the AI technology and great support to explore imaging data using hypothesis-free approach, saving significant experimental time in the identification of predictive histopathological signatures.
Diagnostic Company

Vincent Fert

Chairman & CEO, HalioDx
This partnership with Keen Eye is exemplary as it offers a high complementarity in terms of scientific, technical, and regulatory expertise, but also in terms of field and market access. Both teams are keen to start, as they are very conscious of the impact they can make on patient care with the combination of their respective technologies.

Catherine Genestie

Pathologist in gynecology at Gustave Roussy
I was impressed by Keen Eye's ability to reproduce the pathologist's methodology and annotations using AI. Their platform allows quick interpretation of results for QC inspections.

Meet the Platform

See how you can leverage digital image analysis with our deep learning technologies.